During the past decade, Istituto Mangiagalli conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Istituto Mangiagalli" are "Crohn's Disease" (2 trials), "Epidural; Anesthesia" (1 trials) and "Infant Development" (1 trials). Many other conditions were trialed in "Istituto Mangiagalli" in a lesser frequency.

Most popular intervention types in "Istituto Mangiagalli" are "Drug" (2 trials), "Device" (1 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Mirikizumab" (2 trials), "CompuFlo® Epidural Computer Controlled System" (1 trials), "Formula containing dairy lipids and plant oils" (1 trials), "Formula containing dairy lipids and plant oils, DHA+ARA" (1 trials) and "Formula containing plant oils" (1 trials). Other intervention names were less common.

The vast majority of trials in "Istituto Mangiagalli" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Istituto Mangiagalli". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Istituto Mangiagalli, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Istituto Mangiagalli, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".